Fariba Johari doha

Development of DOTA-Rituximab to be Labeled with 90Y for Radioimmunotherapy of B-cell Non-Hodgkin Lymphoma

S. Rasaneh, S. Shahhosseini, Siyavash Rahmani, 2017, Iranian journal of pharmaceutical research : IJPR.